January 29, 2021
Clinician-scientists Seiichi Yamano and Brian Schmidt to further novel gene therapy strategy to treat oral cancer pain
NYU College of Dentistry clinician-scientists Seiichi Yamano and Brian Schmidt have set out to develop a new class of medicines using gene therapy to effectively and safely treat oral cancer pain. The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health (NIH), has awarded the researchers a five-year, $2.9 million grant (R01DE029694) to test whether nonviral co-delivery of DNA and RNA will safely alleviate oral cancer pain.
To view the full story, please click here.
See more of the latest dentistry news here!
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
read more >>